| Status: | Phase 2 |
| Entry Type: | Antibody |
| UNII: | D3IAG45DAK |
Indications
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL6068083 |
| FDA SRS | D3IAG45DAK |
CONTENTS
| Status: | Phase 2 |
| Entry Type: | Antibody |
| UNII: | D3IAG45DAK |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL6068083 |
| FDA SRS | D3IAG45DAK |